Retinalgenix Technologies Inc.

Medical Devices • Healthcare • Apollo Beach, FL, United States • RTGN (OQB)

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.

415 578 9583 409 Apollo Beach Boulevard, Apollo Beach, FL 33572, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

RetinalGenix Technologies contracts LabCorp to support on DNA/RNA/GPS Pharmaco-Genetic Mapping platform - Ophthalmology Times

Ophthalmology Times • Jul 2

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care - Yahoo Finance

Yahoo Finance • Sep 25

RetinalGenix Technologies Agrees To Hire M. Cory Zwerling as CFO, Interim COO - GlobeNewswire

GlobeNewswire • Dec 8

Dessislava Boneva, MD, joins RetinalGeniX board of directors - Modern Retina

Modern Retina • Dec 17

RetinalGeniX Technologies contracts with MEDsan to provide diagnostic testing services - Ophthalmology Times

Ophthalmology Times • Jan 2

Other Medical Devices Companies

View All →

Abbott Laboratories

$218.91B market cap

Boston Scientific Corp.

Edwards Lifesciences Corp.

$51.04B market cap

Dexcom Inc.

$26.50B market cap

Frequently Asked Questions

Has RetinalGenix Technologies Inc. had layoffs?

No layoff events have been recorded for RetinalGenix Technologies Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is RetinalGenix Technologies Inc. in?

RetinalGenix Technologies Inc. operates in the Medical Devices industry, within the Healthcare sector.

Is RetinalGenix Technologies Inc. a publicly traded company?

Yes, RetinalGenix Technologies Inc. is publicly traded under the ticker symbol RTGN on the OQB. The company has a market capitalization of approximately $0.06 billion.

Where is RetinalGenix Technologies Inc. headquartered?

RetinalGenix Technologies Inc. is headquartered in Apollo Beach, FL, United States at 409 Apollo Beach Boulevard, Apollo Beach, FL 33572, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.